Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for Prevention of Post-Stroke Depression
NCT00177424Phase 4Terminated
- Sponsor
- University of Pittsburgh
- Start
- Jul 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoint: Incidence of Major Depression post-stroke at 12 months. Started Jul 2004; status: terminated.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00177424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177424.